MoonLake Immunotherapeutics MLTX Lessee Operating Lease Liability Undiscounted Excess Amount
Lessee Operating Lease Liability Undiscounted Excess Amount at other companies
Other financials
Where this comes from
Reported directly by MoonLake Immunotherapeutics in its filing.
Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount.
The official record: MoonLake Immunotherapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about MoonLake Immunotherapeutics's lessee operating lease liability undiscounted excess amount.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MoonLake Immunotherapeutics's lessee operating lease liability undiscounted excess amount?
- MoonLake Immunotherapeutics (MLTX) reported lessee operating lease liability undiscounted excess amount of $133K in Q1 2026.
- How has MoonLake Immunotherapeutics's lessee operating lease liability undiscounted excess amount changed year-over-year?
- MoonLake Immunotherapeutics's lessee operating lease liability undiscounted excess amount increased by 8.1% year-over-year, from $123K to $133K.